Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Journal of Clinical Medicine|April 5, 2020
Transient Existence of Circulating Mesenchymal Stem Cells in the Deep Veins in Humans Following Long Bone Intramedullary ReamingSarah M Churchman, Elena A Jones, Tarek Roshdy, et al.Bone|August 3, 2011
High abundance of CD271(+) multipotential stromal cells (MSCs) in intramedullary cavities of long bonesGeorge Cox, Sally A Boxall, Peter V Giannoudis, et al.Arthritis Research & Therapy|December 24, 2014
Modulation of peripheral T-cell function by interleukin-7 in rheumatoid arthritisSarah M Churchman, Jehan J El-Jawhari, Agata N Burska, et al.European Cells & Materials|December 17, 2013
Yield optimisation and molecular characterisation of uncultured CD271+ mesenchymal stem cells in the Reamer Irrigator Aspirator waste bagSarah M Churchman, Dimitrios Kouroupis, Sally A Boxall, et al.Scientific Reports|July 9, 2020
The osteogenic commitment of CD271+CD56+ bone marrow stromal cells (BMSCs) in osteoarthritic femoral head boneDragos C Ilas, Thomas G Baboolal, Sarah M Churchman, et al.Clinical and Experimental Rheumatology|June 19, 2012
Multiplexing immunoassays for cytokine detection in the serum of patients with rheumatoid arthritis: lack of sensitivity and interference by rheumatoid factorSarah M Churchman, Janina Geiler, Rekha Parmar, et al.Arthritis and Rheumatism|March 2, 2012
Transcriptional profile of native CD271+ multipotential stromal cells: evidence for multiple fates, with prominent osteogenic and Wnt pathway signaling activitySarah M Churchman, Frederique Ponchel, Sally A Boxall, et al.Journal of Cutaneous Medicine and Surgery|February 9, 2008
Use of anakinra (Kineret) in the treatment of familial cold autoinflammatory syndrome with a 16-month follow-upJ Barrie Ross, Laura A Finlayson, P Jennifer Klotz, et al.Annals of the Rheumatic Diseases|April 28, 2010
Patients with RA in remission on TNF blockers: when and in whom can TNF blocker therapy be stopped?Benazir Saleem, Helen Keen, Vincent Goeb, et al.Rheumatology (Oxford, England)|December 13, 2016
Interleukin-22 drives the proliferation, migration and osteogenic differentiation of mesenchymal stem cells: a novel cytokine that could contribute to new bone formation in spondyloarthropathiesAhmed A El-Zayadi, Elena A Jones, Sarah M Churchman, et al.Pageof 3